Corresponding Author: Arjun Gupta, MD, Division of Hematology, Oncology & Transplantation, University of Minnesota, 516 Delaware St SE, MMC 480, PWB 14-100, Minneapolis, MN 55455 (arjgupta@umn.edu).
Published Online: May 31, 2022. doi:10.1001/jamainternmed.2022.1812
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient for allowing us to share his story. We thank Anne Blaes, MD; Maryam Lustberg, MD; Charles Loprinzi, MD; Anil Makam, MD; and Ramy Sedhom, MD; for reviewing earlier versions of this article and providing critical input. They were not compensated for their work.
1.Loprinzi
CL , Lacchetti
C , Bleeker
J ,
et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO Guideline update.
J Clin Oncol. 2020;38(28):3325-3348. doi:
10.1200/JCO.20.01399PubMedGoogle ScholarCrossref 2.Jordan
B , Margulies
A , Cardoso
F ,
et al; ESMO Guidelines Committee. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up.
Ann Oncol. 2020;31(10):1306-1319. doi:
10.1016/j.annonc.2020.07.003PubMedGoogle ScholarCrossref 4.Gupta
A , Nshuti
L , Grewal
US ,
et al. Financial burden of drugs prescribed for cancer-associated symptoms.
JCO Oncol Pract. 2022;18(2):140-147.
PubMedGoogle ScholarCrossref